Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 13.63% is 63% below its 4-year average of 36.98%, around the middle of its 4-year range (-68.75%–81.54%).
As of the fiscal period ended Tuesday, June 30, 2026. 65.50% below its 12-month average of 39.49%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 13.63%.
RETURN ON INVESTED CAPITAL (ROIC)
13.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
39.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
33.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-65.50%
CURRENT VS 3Y AVG
-58.90%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 763 covered companies
CURRENT VS SECTOR MEDIAN
+139.19%
vs the sector median at left
biote Corp.
Market Cap
$51.61M
Return on Invested Capital (ROIC)
13.63%
TTM Avg
39.49%
3Y Avg
33.15%
5Y Avg
N/A
Market Cap
$50.48M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-690.86%
3Y Avg
-402.79%
5Y Avg
-302.68%
Market Cap
$51.42M
Return on Invested Capital (ROIC)
-157.40%
TTM Avg
-135.65%
3Y Avg
-123.35%
5Y Avg
-111.97%
Market Cap
$51.33M
Return on Invested Capital (ROIC)
-208.76%
TTM Avg
-1171.68%
3Y Avg
-1173.13%
5Y Avg
-939.08%
Market Cap
$51.24M
Return on Invested Capital (ROIC)
-63.96%
TTM Avg
-125.67%
3Y Avg
-108.34%
5Y Avg
-82.96%
Market Cap
$50.51M
Return on Invested Capital (ROIC)
-192.99%
TTM Avg
-98.03%
3Y Avg
-92.21%
5Y Avg
-72.34%
Market Cap
$52.46M
Return on Invested Capital (ROIC)
-38.04%
TTM Avg
-22.77%
3Y Avg
-89.18%
5Y Avg
-83.00%
Market Cap
$52.47M
Return on Invested Capital (ROIC)
-31665.34%
TTM Avg
-44.53%
3Y Avg
-44.53%
5Y Avg
-44.53%
Market Cap
$50.67M
Return on Invested Capital (ROIC)
-109.13%
TTM Avg
-196.06%
3Y Avg
-152.48%
5Y Avg
-122.21%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| biote Corp. (BTMD) | $51.61M | 13.63% | 39.49% | 33.15% | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.48M | N/A | -690.86% | -402.79% | -302.68% |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | -157.40% | -135.65% | -123.35% | -111.97% |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | -208.76% | -1171.68% | -1173.13% | -939.08% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.24M | -63.96% | -125.67% | -108.34% | -82.96% |
| Celularity Inc. (CELU)vs › | $50.51M | -192.99% | -98.03% | -92.21% | -72.34% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | -38.04% | -22.77% | -89.18% | -83.00% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.47M | -31665.34% | -44.53% | -44.53% | -44.53% |
| Clene Inc. (CLNN)vs › | $50.67M | -109.13% | -196.06% | -152.48% | -122.21% |
| Apollomics, Inc. (APLM)vs › | $50.18M | -2441.49% | -1590.42% | -842.10% | -573.16% |
ROIC
13.6%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 13.63% |
| 2026-03-31 | 34.00% |
| 2025-12-31 | 43.40% |
| 2025-09-30 | 51.40% |
| 2025-06-30 | 55.05% |
| 2025-03-31 | 37.85% |
| 2024-12-31 | 22.62% |
| 2024-09-30 | 42.19% |
| 2024-06-30 | 45.90% |
| 2024-03-31 | 16.30% |
| 2023-12-31 | 20.57% |
| 2023-09-30 | 23.26% |
| 2023-06-30 | 24.82% |
| 2023-03-31 | -59.33% |
| 2022-12-31 | -61.26% |
| 2022-09-30 | -66.46% |
| 2022-06-30 | -68.75% |
| 2022-03-31 | 42.22% |
| 2021-12-31 | 81.54% |
